We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Immune Checkpoint Inhibitors Market Research Report 2016-2026

  • Report Code : 732432
  • Industry : Medical Devices
  • Published On : Oct 2021
  • Pages : 104
  • Publisher : Hey Report
  • Format: WMR PPT FormatWMR PDF Format

Summary

The global Immune Checkpoint Inhibitors market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
PD-1/PD-L1
CTLA-4

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Bristol Myer Squibb
AstraZeneca
Merck & Co.
Roche / Genentech
Incyte Corporation
NewLink Genetics
ArGEN-X
Seattle Genetics
Pfizer
MacroGenics
Celldex Therapeutics
CureTech
Immutep
Innate Pharma
Sorrento Therapeutics
GlaxoSmithKline
GITR, Inc

Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Melanoma
Blood Cancer
Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Immune Checkpoint Inhibitors Picture
1.1.2 Specifications
Table Product Specifications of Immune Checkpoint Inhibitors
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Immune Checkpoint Inhibitors
Table Global Immune Checkpoint Inhibitors Market by Type, 2016-2026 (USD Million)
1.2.1.1 PD-1/PD-L1
Table PD-1/PD-L1 Overview
1.2.1.2 CTLA-4
Table CTLA-4 Overview
1.2.2 by Application
Table Application Segment of Immune Checkpoint Inhibitors
Table Global Immune Checkpoint Inhibitors Market by Application, 2016-2026 (USD Million)
1.2.2.1 Lung Cancer
Table Lung Cancer Overview
1.2.2.2 Colorectal Cancer
Table Colorectal Cancer Overview
1.2.2.3 Breast Cancer
Table Breast Cancer Overview
1.2.2.4 Prostate Cancer
Table Prostate Cancer Overview
1.2.2.5 Melanoma
Table Melanoma Overview
1.2.2.6 Blood Cancer
Table Blood Cancer Overview
1.2.2.7 Others
Table Others Overview
1.2.3 by Regions
Table Global Immune Checkpoint Inhibitors Market by Region, 2016-2026 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Immune Checkpoint Inhibitors
2.2 Upstream
Table Cost of Immune Checkpoint Inhibitors
Figure Manufacturing Process of Immune Checkpoint Inhibitors
2.3 Market
2.3.1 SWOT
Figure SWOT of Immune Checkpoint Inhibitors
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Immune Checkpoint Inhibitors
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Immune Checkpoint Inhibitors
3.4 Market Entry
Table Market Entry of Immune Checkpoint Inhibitors
4 Market Segmentation by Type
4.1 Market Size
4.1.1 PD-1/PD-L1 Market, 2016-2020
Figure PD-1/PD-L1 Market Size and Growth, 2016-2020 (USD Million)
Figure PD-1/PD-L1 Market Size and Growth, 2016-2020 (in Volume)
Table PD-1/PD-L1 CAGR by Revenue and Volume, 2016-2020
4.1.2 CTLA-4 Market, 2016-2020
Figure CTLA-4 Market Size and Growth, 2016-2020 (USD Million)
Figure CTLA-4 Market Size and Growth, 2016-2020 (in Volume)
Table CTLA-4 CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
4.2.1 PD-1/PD-L1 Market Forecast, 2021-2026
Figure PD-1/PD-L1 Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure PD-1/PD-L1 Market Estimates and Forecasts, 2021-2026 (in Volume)
Table PD-1/PD-L1 CAGR by Revenue and Volume, 2016-2026
4.2.2 CTLA-4 Market Forecast, 2021-2026
Figure CTLA-4 Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure CTLA-4 Market Estimates and Forecasts, 2021-2026 (in Volume)
Table CTLA-4 CAGR by Revenue and Volume, 2016-2026
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Lung Cancer Market, 2016-2020
Figure Lung Cancer Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Lung Cancer CAGR by Revenue and Volume, 2016-2020
5.1.2 Colorectal Cancer Market, 2016-2020
Figure Colorectal Cancer Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Colorectal Cancer CAGR by Revenue and Volume, 2016-2020
5.1.3 Breast Cancer Market, 2016-2020
Figure Breast Cancer Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Breast Cancer CAGR by Revenue and Volume, 2016-2020
5.1.4 Prostate Cancer Market, 2016-2020
Figure Prostate Cancer Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Prostate Cancer CAGR by Revenue and Volume, 2016-2020
5.1.5 Melanoma Market, 2016-2020
Figure Melanoma Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Melanoma CAGR by Revenue and Volume, 2016-2020
5.1.6 Blood Cancer Market, 2016-2020
Figure Blood Cancer Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Blood Cancer CAGR by Revenue and Volume, 2016-2020
5.1.7 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
5.2.1 Lung Cancer Market Forecast, 2021-2026
Figure Lung Cancer Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Lung Cancer Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Lung Cancer CAGR by Revenue and Volume, 2021-2026
5.2.2 Colorectal Cancer Market Forecast, 2021-2026
Figure Colorectal Cancer Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Colorectal Cancer Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Colorectal Cancer CAGR by Revenue and Volume, 2021-2026
5.2.3 Breast Cancer Market Forecast, 2021-2026
Figure Breast Cancer Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Breast Cancer Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Breast Cancer CAGR by Revenue and Volume, 2021-2026
5.2.4 Prostate Cancer Market Forecast, 2021-2026
Figure Prostate Cancer Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Prostate Cancer Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Prostate Cancer CAGR by Revenue and Volume, 2021-2026
5.2.5 Melanoma Market Forecast, 2021-2026
Figure Melanoma Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Melanoma Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Melanoma CAGR by Revenue and Volume, 2021-2026
5.2.6 Blood Cancer Market Forecast, 2021-2026
Figure Blood Cancer Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Blood Cancer Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Blood Cancer CAGR by Revenue and Volume, 2021-2026
5.2.7 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2021-2026
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2021-2026
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
6.2.2 North America Market Forecast, 2021-2026
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2026
6.2.3 Europe Market Forecast, 2021-2026
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2026
6.2.4 South America Market Forecast, 2021-2026
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2026
6.2.5 Middle East & Africa Market Forecast, 2021-2026
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
7 Market Competitive
7.1 Global Market by Vendors
Table Global Immune Checkpoint Inhibitors Market by Vendors, 2016-2020 (in Volume)
Table Global Immune Checkpoint Inhibitors Market Share by Vendors, 2016-2020 (USD Million)
Table Global Immune Checkpoint Inhibitors Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure Immune Checkpoint Inhibitors Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Bristol Myer Squibb
Table Bristol Myer Squibb Profile List
Table Microecological Modulator Operating Data of Bristol Myer Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 AstraZeneca
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Merck & Co.
Table Merck & Co. Profile List
Table Microecological Modulator Operating Data of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Roche / Genentech
Table Roche / Genentech Profile List
Table Microecological Modulator Operating Data of Roche / Genentech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Incyte Corporation
Table Incyte Corporation Profile List
Table Microecological Modulator Operating Data of Incyte Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 NewLink Genetics
Table NewLink Genetics Profile List
Table Microecological Modulator Operating Data of NewLink Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 ArGEN-X
Table ArGEN-X Profile List
Table Microecological Modulator Operating Data of ArGEN-X (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Seattle Genetics
Table Seattle Genetics Profile List
Table Microecological Modulator Operating Data of Seattle Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Pfizer
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 MacroGenics
Table MacroGenics Profile List
Table Microecological Modulator Operating Data of MacroGenics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Celldex Therapeutics
Table Celldex Therapeutics Profile List
Table Microecological Modulator Operating Data of Celldex Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 CureTech
Table CureTech Profile List
Table Microecological Modulator Operating Data of CureTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Immutep
Table Immutep Profile List
Table Microecological Modulator Operating Data of Immutep (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Innate Pharma
Table Innate Pharma Profile List
Table Microecological Modulator Operating Data of Innate Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Sorrento Therapeutics
Table Sorrento Therapeutics Profile List
Table Microecological Modulator Operating Data of Sorrento Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 GlaxoSmithKline
Table GlaxoSmithKline Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 GITR, Inc
Table GITR, Inc Profile List
Table Microecological Modulator Operating Data of GITR, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
  • Types
  • Applications
  • Technology
  • End-use Industries
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers and restraints
  • Regulatory scenario
  • Industry trend
  • Pestle analysis
  • Porter’s analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Competitive landscape
It helps the businesses in making strategic decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved